New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 19, 2020, Evoke Pharma announced the FDA approval of Gimoti (metoclopramide), for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
Download PDF
Return to publications
